Filing Details
- Accession Number:
- 0001094891-16-000493
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-23 13:15:56
- Reporting Period:
- 2016-05-20
- Filing Date:
- 2016-05-23
- Accepted Time:
- 2016-05-23 13:15:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1619551 | Cb Pharma Acquisition Corp. | CNLM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
941841 | Md A Lindsay Rosenwald | C/O Cb Pharma Acquisition Corp. 2 Gansevoort Street, 9Th Floor New York NY 10014 | Co-Chairman And Ceo | Yes | Yes | Yes | No |
1429260 | Fortress Biotech, Inc. | 3 Columbus Circle, 15Th Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2016-05-20 | 1,020,000 | $0.00 | 265,000 | No | 4 | S | Indirect | By Fortress Biotech, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Fortress Biotech, Inc. |
Footnotes
- Mr. Rosenwald is the Chairman, President and Chief Executive Officer of Fortress Biotech, Inc. (formerly Coronado Biosciences, Inc.), and as such, controls the voting and disposition of such securities. Mr. Rosenwald disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that Mr. Rosenwald is the beneficial owner of these securities for puposes of Section 16 or for any other purpose.
- $0.00000095238 per ordinary share.